BlackRock’s Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HTPA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-567,393
Closed -$21K 5954
2022
Q3
$21K Buy
567,393
+1
+0% ﹤0.01% 5509
2022
Q2
$74K Sell
567,392
-619
-0.1% -$134 ﹤0.01% 5319
2022
Q1
$176K Buy
+568,011
New +$592K ﹤0.01% 5136

BlackRock's HTPA.WS Position: Q4 2022 in Review

BlackRock sold out of Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HTPA.WS) in Q4 2022, closing a stake of 567,393 shares — an estimated $21K sold.

BlackRock first reported a position in HTPA.WS in Q1 2022 and held it in 3 quarters. The position peaked at $176K in Q1 2022. 0 funds tracked by Wall St. Rank hold HTPA.WS as of Q4 2022.

  • BlackRock reported no remaining Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • BlackRock sold 567,393 Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022, an estimated $21K.
  • BlackRock first reported a position in Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 3 quarters.
  • BlackRock's Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $176K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.